Depo-Provera Label Updated: FDA Warns of Possible Brain Tumor Risk
December 20, 2025
Brand Name :
N/A
Synonyms :
moperone
Class :
Anti-Psychotic Agents
In vivo dosing suggests administration of 0.2 to 0.3mg/kg everyday as initial dose.
Can increase the dose slowly to 0.04 to 0.06mg/kg everyday
Safety and Efficacy not established
Refer adult dosing
Actions and Spectrum:
N/A
Black box warning:
None
Contraindications/caution:
Contraindications:
Hypersensitivity or Allergy: Individuals with known hypersensitivity or allergy to moperone or other butyrophenones should avoid its use.
Caution:
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacokinetics:
N/A
Administration:
Oral administration
moperone is usually taken by mouth (orally).
Patient information leaflet
Generic Name: moperone
Why do we use moperone?
moperone is an anti-psychotic medication primarily used in the treatment of psychiatric disorders. Here are some of the common uses of moperone:
Anxiety and Agitation in the Elderly: In some cases, moperone may be utilized to address anxiety and agitation in the elderly population.